| Nasdaq: IRIX
IRIDEX Corp. develops, manufactures, and markets light-based medical systems and delivery devices. The company offers laser based solutions for multiple specialties, including aesthetic medicine, ophthalmology, and otolaryngology. Its ophthalmology products consist of laser systems, delivery devices and consumable instrumentation, including laser probes and are used in the treatment of serious eye diseases, including the three leading causes of irreversible blindness: diabetic retinopathy, glaucoma and age-related macular degeneration. The company's ophthalmology products are also often used in vitrectomy procedures, which are generally performed in the operating room and require a consumable single use intraocular laser probe to deliver light to the back of the eye together with other instrumentation. Its aesthetics products consist of laser systems and hand pieces that focus on the treatment of pigmented and vascular lesions, skin rejuvenation, skin tightening, hair reduction, leg veins, and acne. The company's aesthetics products include the VariLite, DioLite XP, Gemini, Aura-i, Lyra-i, and Venus-i Laser Systems. Its aesthetics products are primarily used by dermatologists and plastic surgeons. IRIDEX was founded by Eduardo Arias, Theodore A. Boutacoff and James L. Donovan on February 1, 1989 and is headquartered in Mountain View, CA.